Departments of Biomolecular Sciences, Weizmann Institute of Science, Rehovot 7610001, Israel.
Departments of Biological Regulation, Weizmann Institute of Science, Rehovot 7610001, Israel.
Biochim Biophys Acta Mol Basis Dis. 2021 Mar 1;1867(3):166041. doi: 10.1016/j.bbadis.2020.166041. Epub 2020 Dec 16.
Accumulating evidence arising from numerous clinical studies indicate that assembled and functional 20S proteasome complexes circulate freely in plasma. Elevated levels of this core proteolytic complex have been found in the plasma of patients suffering from blood, skin and solid cancers, autoimmune disorders, trauma and sepsis. Moreover, in various diseases, there is a positive correlation between circulating 20S proteasome (c20S) levels and treatment efficacy and survival rates, suggesting the involvement of this under-studied c20S complex in pathophysiology. However, many aspects of this system remain enigmatic, as we still do not know the origin, biological role or mechanisms of extracellular transport and regulation of c20S proteasomes. In this review, we provide an overview of the current understanding of the c20S proteasome system and discuss the remaining gaps in knowledge.
越来越多的临床研究证据表明,组装和功能齐全的 20S 蛋白酶体复合物在血浆中自由循环。患有血液、皮肤和实体癌、自身免疫性疾病、创伤和败血症的患者的血浆中发现了这种核心蛋白水解复合物的水平升高。此外,在各种疾病中,循环 20S 蛋白酶体 (c20S) 水平与治疗效果和存活率呈正相关,这表明这个研究较少的 c20S 复合物参与了病理生理学。然而,该系统的许多方面仍然很神秘,因为我们仍然不知道 c20S 蛋白酶体的起源、生物学作用或细胞外运输和调节的机制。在这篇综述中,我们概述了目前对 c20S 蛋白酶体系统的理解,并讨论了知识中的遗留空白。